Frequently Asked Questions

MAPflow contains all minor ailments within scope in Ontario.

Yes! The COVID-19 module, which allows pharmacists to assess for the condition and prescribe Paxlovid™ if appropriate (based on Ontario guidance) is available on MAPflow and is included in the annual subscription price.

When regulations change, the algorithms will be updated immediately. When clinical practice guidelines and standards change, the algorithms will be updated within 6 months. In the absence of regulatory or clinical guideline changes, the assessment algorithms will be reviewed and updated annually by content experts, spearheaded by Dr. Nardine Nakhla.

When hovering over a box for an answer option that will lead to medical referral, it will be highlighted in red. This is to ensure you know why, if you click next, a referral will be prompted.

Yes, you can be certain that the prescription agents found within MAPflow algorithms will be within scope for the given ailments (listed in Schedule 4 of the regulations) and have taken into account any agents available in Canada only.

Throughout each algorithm, there are tool tips that provide you with additional information to facilitate just-in-time learning as well as definitions of terms. For CPS Full Access subscribers, a link to the relevant chapter in the CPS will be displayed whenever an assessment is being conducted.

We value your feedback. Please contact us with your concerns.